Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin vs Corticosteroid for Tennis Elbow
NCT00395616Phase 2Unknown
- Sponsor
- E-Da Hospital
- Start
- Nov 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of botulinum toxin type A in Lateral Epicondylitis (LET) (2 arms), sponsored by E-Da Hospital. Primary endpoints: Visual Analogue Scale for Pain at 12 weeks, Pain-free Grip Strength at 12 weeks and 1 more. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
Lateral Epicondylitis (LET)
Beyond the preview
Go deeper on NCT00395616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00395616.